Li Y, Huang Z, Xu L, Fan Y, Ping J, Li G
Nat Methods. 2025; .
PMID: 39833568
DOI: 10.1038/s41592-024-02586-y.
Jia H, Bernard L, Chen J, Du S, Steffen L, Wong K
J Nutr. 2024; 154(11):3266-3273.
PMID: 39341601
PMC: 11600109.
DOI: 10.1016/j.tjnut.2024.09.024.
Zhang D, Ma B, Liu D, Wu W, Zhou T, Gao Y
EBioMedicine. 2024; 105:105212.
PMID: 38954976
PMC: 11261775.
DOI: 10.1016/j.ebiom.2024.105212.
Bhattacharya S, Tu B
J Cell Sci. 2024; 137(11).
PMID: 38842578
PMC: 11213524.
DOI: 10.1242/jcs.261250.
Yang J, Kinyamu H, Ward J, Scappini E, Muse G, Archer T
Stem Cells. 2024; 42(8):706-719.
PMID: 38825983
PMC: 11291304.
DOI: 10.1093/stmcls/sxae039.
Super-enhancers: drivers of cells' identities and cells' debacles.
Lavaud M, Tesfaye R, Lassous L, Brounais B, Baudhuin M, Verrecchia F
Epigenomics. 2024; .
PMID: 38587919
PMC: 11160454.
DOI: 10.2217/epi-2023-0409.
Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders.
Dhulkifle H, Diab M, Algonaiah M, Korashy H, Maayah Z
ACS Pharmacol Transl Sci. 2024; 7(3):546-559.
PMID: 38481679
PMC: 10928887.
DOI: 10.1021/acsptsci.3c00219.
and genes independently evolved RNA structures to control unproductive splicing.
Petrova M, Margasyuk S, Vorobeva M, Skvortsov D, Dontsova O, Pervouchine D
NAR Genom Bioinform. 2024; 6(1):lqad113.
PMID: 38226395
PMC: 10789245.
DOI: 10.1093/nargab/lqad113.
Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy.
Wang Z, Zhang Z, Wu Y, Pi Y, Lou S, Liu T
Signal Transduct Target Ther. 2023; 8(1):420.
PMID: 37926722
PMC: 10625992.
DOI: 10.1038/s41392-023-01647-6.
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors.
Elshazly A, Gewirtz D
Int J Mol Sci. 2023; 24(16).
PMID: 37628849
PMC: 10454099.
DOI: 10.3390/ijms241612669.
Spotlight on Plant Bromodomain Proteins.
Bardani E, Kallemi P, Tselika M, Katsarou K, Kalantidis K
Biology (Basel). 2023; 12(8).
PMID: 37626962
PMC: 10451976.
DOI: 10.3390/biology12081076.
BRD7 improves glucose homeostasis independent of IRS proteins.
Kim Y, Lee J, Han Y, Tao R, White M, Liu R
J Endocrinol. 2023; 258(3).
PMID: 37578842
PMC: 10430774.
DOI: 10.1530/JOE-23-0119.
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1.
Mumby S, Perros F, Grynblat J, Manaud G, Papi A, Casolari P
Respir Res. 2023; 24(1):193.
PMID: 37516840
PMC: 10386603.
DOI: 10.1186/s12931-023-02499-y.
A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation.
Plant E, Bellefroid M, Van Lint C
Retrovirology. 2023; 20(1):11.
PMID: 37268923
PMC: 10236774.
DOI: 10.1186/s12977-023-00623-w.
Bromodomain-containing protein 9 activates proliferation and epithelial-mesenchymal transition of colorectal cancer via the estrogen pathway and .
Chen P, Du R, Chang Z, Gao W, Zhao W, Dong G
J Gastrointest Oncol. 2023; 14(2):980-996.
PMID: 37201092
PMC: 10186543.
DOI: 10.21037/jgo-23-271.
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications.
To K, Xing E, Larue R, Li P
Molecules. 2023; 28(7).
PMID: 37049806
PMC: 10096006.
DOI: 10.3390/molecules28073043.
Genome-wide analysis of bromodomain gene family in Arabidopsis and rice.
Abiraami T, Sanyal R, Misra H, Saini A
Front Plant Sci. 2023; 14:1120012.
PMID: 36968369
PMC: 10030601.
DOI: 10.3389/fpls.2023.1120012.
Native Mass Spectrometry of BRD4 Bromodomains Linked to a Long Disordered Region.
Azegami N, Taguchi R, Suzuki N, Sakata Y, Konuma T, Akashi S
Mass Spectrom (Tokyo). 2023; 11(1):A0110.
PMID: 36713808
PMC: 9853951.
DOI: 10.5702/massspectrometry.A0110.
Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies.
Gaal Z
Biomolecules. 2023; 13(1).
PMID: 36671446
PMC: 9855367.
DOI: 10.3390/biom13010061.
The epigenetic regulator BRD4 is required for myofibroblast differentiation of knee fibroblasts.
Dudakovic A, Bayram B, Bettencourt J, Limberg A, Galvan M, Carrasco M
J Cell Biochem. 2023; 124(2):320-334.
PMID: 36648754
PMC: 9990907.
DOI: 10.1002/jcb.30368.